Trends in anemia management in hemodialysis patients with cancer

BACKGROUND: Erythropoiesis-stimulating agents (ESAs), intravenous iron, and blood transfusion are used to treat anemia in both end-stage renal disease (ESRD) and cancer. However, anemia treatment patterns have not been described among ESRD patients undergoing hemodialysis with concurrent cancer, esp...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Nephrol
Main Authors: Butler, Anne M., Kshirsagar, Abhijit V., Olshan, Andrew F., Nielsen, Matthew E., Wheeler, Stephanie B., Brookhart, M. Alan
Format: Artigo
Jezik:Inglês
Izdano: 2015
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4618160/
https://ncbi.nlm.nih.gov/pubmed/26439712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000440771
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki